Christopher Cotter

Christopher Cotter, Ph.D., is a Senior Clinical Scientist at Genentech and Roche, bringing over a decade of expertise in clinical and preclinical drug development with a focus on immunotherapies for gastrointestinal cancer. Previously, as a Lead Clinical Scientist, they directed Phase I/II global clinical trials, authoring study protocols and ensuring compliance with regulatory standards. Their early career included impactful roles at MedImmune and Health Interactions, where they contributed significantly to vaccine development and scientific communications, respectively. Cotter earned a Ph.D. in Biomedical Science from the Icahn School of Medicine at Mount Sinai and a B.S. in Biology from Manhattan College.